Search Results 21-30 of 17389 for Interferon

  1. C Clinical Trials - Mayo Clinic Research

    ... interferon and RBV. The primary study hypothesis is that in at least one of the study arms, the percentage of participants achieving sustained viral ...

  2. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    ... Interferon + Ribavirin (MK-5172-068). Print details. Share; Facebook · Twitter ... interferon and RBV. The primary study hypothesis is that in at least one ...

  3. Ribavirin (oral route) - Side effects & dosage - Mayo Clinic

    Ribavirin is used in combination with injectable interferon alfa-2b, peginterferon alfa-2a, or peginterferon alfa-2b to treat chronic hepatitis C infection.

  4. Myelofibrosis Clinical Trials - Mayo Clinic Research

    ... interferon alpha-2b) in treating patients with myelofibrosis. PEG-proline-interferon alpha-2b is a substance that can improve the body's natural response ...

  5. High-risk nonmuscle invasive bladder cancer - Mayo Clinic

    ... interferon alfa-2b limits longer term treatment efficacy. The novel gene therapy approach provides a longer duration of exposure to the interferon alfa-2b ...

  6. Patients with skin disease show response to targeted treatment - Mayo Clinic News Network

    Cytokines are small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells. They include interferon-gamma ...

  7. Peyronie's disease - Diagnosis and treatment - Mayo Clinic

    Interferon also has been shown to ease penile pain in people with Peyronie's disease. Ask your health care professional about the side effects of any medicine ...

  8. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    rAd-IFN is a non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the interferon alpha-2b (IFNα2b) gene. Syn 3 is clinical surfactant excipient ...

  9. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    The atezolizumab plus interferon alfa-2b arm (Arm B), plus pegylated interferon alfa-2a (PEG−interferon alfa-2a, Arm C), and atezolizumab plus PEG-interferon ...

  10. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

    PEG-proline-interferon alpha-2b is a substance that can improve the body's natural response and may slow the growth of myelofibrosis. Participation eligibility.